Skip to content

VERAPHARM: what changed

BE 0479.036.577NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€37,249
2024 · €48,060-€10,811
Equity
€232,349
2024 · €206,181+€26,168
Cash
€126,282
2024 · €153,901-€27,619
Balance sheet total
€327,020
2024 · €320,785+€6,235

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€28,938

    up €28,938 (+61.7%), from €46,896 to €75,835

    of which Plant, machinery and equipment: +€36,333

  • Cash -€27,619

    down €27,619 (-17.9%), from €153,901 to €126,282

    mainly Investment in fixed assets (net) (-€43,252) and Other debts (-€31,487)

  • Stocks and contracts +€7,943

    up €7,943 (+9.6%), from €82,538 to €90,481

  • Receivables within one year -€4,861

    down €4,861 (-15.0%), from €32,369 to €27,508

    of which Trade receivables: -€15,310

Equity and liabilities
  • Other debts -€31,487

    down €31,487 (-47.1%), from €66,908 to €35,421

  • Reserves +€26,168

    up €26,168 (+14.0%), from €187,581 to €213,749

  • Trade debts +€10,459

    up €10,459 (+23.8%), from €43,990 to €54,450

Income statement
  • Gross operating margin -€6,670

    down €6,670 (-6.6%), from €101,728 to €95,058

  • Depreciation +€4,481

    up €4,481 (+45.6%), from €9,833 to €14,314

  • Taxes -€3,569

    down €3,569 (-28.3%), from €12,612 to €9,043

  • Staff costs +€3,183

    up €3,183 (+22.5%), from €14,177 to €17,360

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €48,060
Gross operating margin -€6,670
Staff costs -€3,183
Depreciation -€4,481
Other operating charges +€644
Financial income -€33
Financial charges -€655
Taxes +€3,569
Result 2025 €37,249
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€26,715
Investment -€43,252
Financing -€11,081
Cash 2024 €153,901
Net result for the year +€37,249
Depreciation +€14,314
Stocks and contracts -€7,943
Receivables within one year +€4,861
Deferred charges and accrued income -€1,833
Trade debts +€10,459
Tax, wage and social debts -€782
Other debts -€31,487
Accrued charges and deferred income +€1,876
Investment in fixed assets (net) -€43,252
Contributions, distributions and other -€11,081
Cash 2025 €126,282
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €320,785 €327,020 +€6,235 +1.9%
Fixed assets 21/28 €47,396 €76,335 +€28,938 +61.1%
Tangible fixed assets 22/27 €46,896 €75,835 +€28,938 +61.7%
Plant, machinery and equipment 23 €21,570 €57,904 +€36,333 +168%
Furniture and vehicles 24 €25,326 €17,931 -€7,395 -29.2%
Financial fixed assets 28 €500 €500 = 0.0%
Current assets 29/58 €273,389 €250,685 -€22,703 -8.3%
Stocks and contracts in progress 3 €82,538 €90,481 +€7,943 +9.6%
Stocks 30/36 €82,538 €90,481 +€7,943 +9.6%
Amounts receivable within one year 40/41 €32,369 €27,508 -€4,861 -15.0%
Trade receivables 40 €32,211 €16,901 -€15,310 -47.5%
Other amounts receivable 41 €158 €10,606 +€10,448 +6,617%
Cash at bank and in hand 54/58 €153,901 €126,282 -€27,619 -17.9%
Deferred charges and accrued income 490/1 €4,581 €6,414 +€1,833 +40.0%
Total equity and liabilities 10/49 €320,785 €327,020 +€6,235 +1.9%
Equity 10/15 €206,181 €232,349 +€26,168 +12.7%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €187,581 €213,749 +€26,168 +14.0%
Distributable reserves 133 €187,581 €213,749 +€26,168 +14.0%
Amounts payable 17/49 €114,604 €94,671 -€19,933 -17.4%
Amounts payable within one year 42/48 €114,464 €92,655 -€21,810 -19.1%
Trade debts 44 €43,990 €54,450 +€10,459 +23.8%
Suppliers 440/4 €43,990 €54,450 +€10,459 +23.8%
Taxes, remuneration and social security 45 €3,566 €2,784 -€782 -21.9%
Taxes 450/3 €1,119 €229 -€890 -79.5%
Remuneration and social security 454/9 €2,448 €2,555 +€107 +4.4%
Other amounts payable 47/48 €66,908 €35,421 -€31,487 -47.1%
Accrued charges and deferred income 492/3 €140 €2,016 +€1,876 +1,342%
Remuneration, social security and pensions 62 €14,177 €17,360 +€3,183 +22.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €9,833 €14,314 +€4,481 +45.6%
Other operating charges 640/8 €3,278 €2,634 -€644 -19.6%
Gross operating margin 9900 €101,728 €95,058 -€6,670 -6.6%
Operating profit (loss) 9901 €74,440 €60,749 -€13,691 -18.4%
Financial income 75/76B €758 €725 -€33 -4.4%
Recurring financial income 75 €758 €725 -€33 -4.4%
Financial charges 65/66B €14,526 €15,181 +€655 +4.5%
Recurring financial charges 65 €14,526 €15,181 +€655 +4.5%
Profit (loss) for the period before taxes 9903 €60,672 €46,292 -€14,379 -23.7%
Income taxes 67/77 €12,612 €9,043 -€3,569 -28.3%
Profit (loss) for the period 9904 €48,060 €37,249 -€10,811 -22.5%
Profit (loss) for the period to be appropriated 9905 €48,060 €37,249 -€10,811 -22.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€264,649 to €324,039

Midpoint €289,395 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €232,349
Capitalised earnings €296,950 to €415,730
Indication €264,649 to €324,039

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€232,349
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€232,349

Capitalised earnings

net result for the year (9904)
2025
€37,249
2024
€48,060
2023
€51,409
excluding non-recurring income and charges
€39,409
2022
€36,515
2021
€12,741
Average result, excluding non-recurring income and charges
€41,573
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€296,950 / €346,442 / €415,730

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.